Fermentalg SA
PAR:FALG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.265
0.925
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Fermentalg SA
Fermentalg SA
Cash Equivalents
Fermentalg SA
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fermentalg SA
PAR:FALG
|
Cash Equivalents
€11.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Robertet SA
PAR:RBT
|
Cash Equivalents
€161.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Baikowski SA
PAR:ALBKK
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sergeferrari Group SA
PAR:SEFER
|
Cash Equivalents
€431k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Orapi SA
PAR:ORAP
|
Cash Equivalents
€11.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
|
G
|
Groupe Berkem SA
PAR:ALKEM
|
Cash Equivalents
€19k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fermentalg SA
Glance View
Fermentalg SA is an industrial biotechnology firm which engages in the production of chemical compounds from microalgae. The company is headquartered in Libourne, Nouvelle-Aquitaine. The company went IPO on 2014-04-16. The company specializes in the development of a technology which is used to produce molecules of interest and bypasses conventional methods using petrochemicals and also industrial fish farming. The firm offers a solution to the gradual depletion of two key resources: wild fish and petroleum. The firm's technology allows it to target a range of markets, such as human nutrition, animal feed, green chemicals, cosmetics and biofuels.
See Also
What is Fermentalg SA's Cash Equivalents?
Cash Equivalents
11.2m
EUR
Based on the financial report for Dec 31, 2023, Fermentalg SA's Cash Equivalents amounts to 11.2m EUR.
What is Fermentalg SA's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-1%
Over the last year, the Cash Equivalents growth was 86%. The average annual Cash Equivalents growth rates for Fermentalg SA have been 4% over the past three years , -1% over the past five years .
You don't have any saved screeners yet